Nakayama, Yoichi
Onishi, Akira
Yamamoto, Wataru
Yoshikawa, Ayaka
Shiba, Hideyuki
Yoshida, Naofumi
Son, Yonsu
Shirasugi, Iku
Maeda, Toshihisa
Katsushima, Masao
Hashimoto, Motomu
Etani, Yuki
Itami, Tetsu
Nozaki, Yuji
Onizawa, Hideo
Fujii, Takayuki
Murakami, Kosaku
Murata, Koichi
Tanaka, Masao
Matsuda, Shuichi
Morinobu, Akio
Article History
Received: 27 February 2024
Accepted: 21 April 2024
First Online: 10 May 2024
Declarations
:
: YNakayama received speaker fees from Asahi Kasei Pharma Corp., Chugai Pharmaceutical Co., and AbbVie Inc. AO received research grants and speaker fees from Pfizer Inc., Bristol Myers Squibb, Advantest, Asahi Kasei Pharma Corp., Chugai Pharmaceutical Co. Ltd., Eli Lilly Japan K. K., Ono Pharmaceutical Co., UCB Japan Co., Mitsubishi Tanabe Pharma Co., Eisai Co. Ltd., AbbVie Inc., Takeda Pharmaceutical Co. Ltd., and Daiichi Sankyo Co. Ltd. YS has received speaking fees from Pfizer Inc., Chugai Pharmaceutical Co., Ltd., Janssen Pharmaceutical K.K., Eisai Co., Ltd., and AbbVie G.K. TM received speaker fees from AbbVie, Asahi Kasei, Astellas, Asympti, Bristol-Myers Squibb, Chugai, Daiichi Sankyo, Eisai, Eli Lilly, Janssen, Mitsubishi Tanabe, Novartis Pharma, Ono Pharmaceutical, Pfizer, Sanofi, Taisho, and UCB, Japan. MH received research grants and/or speaker fees from AbbVie, Asahi Kasei, Astellas, Brystol Meyers, Chugai, EA Pharma, Eisai, Daiichi Sankyo, Eli Lilly, Novartis Pharma, Taisho Toyama, and Tanabe Mitsubishi. YE received research grants and/or speaker fees from Asahi Kasei, Eisai, Eli Lilly, Mitsubishi Tanabe, Ono Pharmaceuticals, and Taisho. YE is affiliated with the Department of Musculoskeletal Regenerative Medicine, Osaka University Graduate School of Medicine, supported by Taisho. YNozaki has received research grants from AbbVie Japan GK, Eisai Co., and Mitsubishi Tanabe Pharma Corp. and speaker fees from AbbVie Japan GK, Astellas Pharma, Asahi Kasei, Chugai Pharmaceutical Co., Eisai Co., Eli Lilly Japan K.K., Daiichi-Sankyo, GlaxoSmithKline K.K., Mitsubishi Tanabe Pharma Corp., Novartis Japan, Takeda, Ono, Otsuka Co., Pfizer, Janssen, and UCB Japan. TF has received speaker fees from AbbVie GK, Asahi Kasei Pharma Corp., Chugai Pharmaceutical Co., Ltd., Eisai Co., Ltd., and Janssen Pharmaceutical K.K. KMurakami received research grants and/or speaker fees from Eisai Co., Ltd., Chugai Pharmaceutical Co., Ltd., Pfizer Inc., Bristol-Myers Squibb, Mitsubishi Tanabe Pharma Corporation, UCB Japan Co., Ltd., Daiichi Sankyo Co., Ltd., and Astellas Pharma Inc. KMurata received speaking and/or consulting fees from AbbVie GK, Eisai Co., Ltd., Pfizer Inc., Chugai Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corp., Bristol-Myers Squibb, Daiichi Sankyo Co., Ltd., Janssen Pharmaceutical K.K., and Asahi Kasei Pharma Corp. MT belongs to the department financially supported by two local governments in Japan (Nagahama City, Shiga and Toyooka City, Hyogo) and two pharmaceutical companies (Ayumi Pharmaceutical Corp. and Asahi Kasei Pharma Corp.). MT has received research grants and/or speaker fees from AbbVie GK, Asahi Kasei Pharma Corp., Astellas Pharma Inc., Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Eisai Co., Ltd., Eli Lilly Japan K.K., Janssen Pharmaceutical K.K., Kyowa Kirin Co., Ltd., Pfizer Inc., Taisho Pharmaceutical Co., Ltd., Tanabe Mitsubishi Pharma Corp., Teijin Pharma, Ltd., UCB Japan Co., Ltd.SM received research grants and/or speaker fees from Takeda, Eisai, Asahi-Kasei, Astellas, Pfizer, Taisho, Mitsubishi-Tanabe, and Chugai. AM received honorarium and research grants from AbbVie G.K., Chugai Pharmaceutical Co. Ltd., Eli Lilly Japan K.K., Eisai Co. Ltd., Pfizer Inc., Bristol-Myers Squibb., Mitsubishi Tanabe Pharma Co., Astellas Pharma Inc., Asahi Kasei Pharma Corp., and Gilead Sciences Japan. WY, AY, HS, NY, IS, MK, TI, and HO have no financial conflicts of interest to disclose concerning this manuscript.
: All study participants provided written informed consent and the study design was approved by the appropriate ethics review board. The representative facility of this registry is Kyoto University. This observational study (not a clinical trial) was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of Kyoto University (approval number R0357).
: All study participants provided written informed consent.
: Not applicable.